Top Markets
Coin of the day
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
Κατάταξη σε μετοχές #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
Τιμή μετοχής
$0.94
Τελευταίος συγχρονισμός: 2025-02-28
Κεφαλαιοποίηση
$2.73M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
0.00%
Χώρα
US
Εμπόριο Fresh Tracks Therapeutics, Inc. (FRTX)

Κατηγορία

Ιστορικό τιμής μετοχής για την Fresh Tracks Therapeutics, Inc. (FRTX)
Υψηλότερη τιμή κλεισίματος: $0.93 στις 2025-02-01

Χαμηλότερη τιμή κλεισίματος: $17.60K στις 1993-03-01
Ιστορικό τιμής μετοχής της Fresh Tracks Therapeutics, Inc. από 1993 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2025 25.41%
2024 -12.67%
2023 -44.20%
2022 -87.64%
2021 -62.29%
2020 -56.41%
2019 -79.67%
2018 -35.82%
2017 -21.99%
2016 -41.65%
2015 -62.32%
2014 -5.40%
2013 -62.56%
2012 -33.38%
2011 129.70%
2010 -33.25%
2009 132.91%
2008 -71.15%
2007 -34.72%
2006 40.95%
2005 4.97%
2004 -6.60%
2003 35.73%
2002 -70.26%
2001 -36.17%
2000 -14.37%
1999 47.84%
1998 16.60%
1997 -25.73%
1996 63.98%
1995 35.35%
1994 -42.99%
1993 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE